Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model.

Frontiers in immunology·2026
Same author

RT-AFNet: A Hybrid ResNet-Transformer Architecture with Multi-Scale Fusion for Atrial Fibrillation Detection.

Biosensors·2026
Same author

Genetic Identification of Potential Drug Targets for Dental Caries: A Mendelian Randomization Study.

Health science reports·2026
Same author

Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up.

American journal of hematology·2026
Same author

Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study.

Frontiers in immunology·2026
Same author

TRIM37-Mediated Ubiquitination and Degradation of KMT2D Activates JAK2-STAT3 Signaling to Promote Diffuse Large B-Cell Lymphoma Progression.

Hematological oncology·2026
Same journal

Structural basis of complex assembly and nucleosome recognition by the chromatin remodeling ncBAF complex.

Journal of molecular cell biology·2026
Same journal

Microtubule-associated CCDC112 is essential for spermiogenesis and male fertility in mice.

Journal of molecular cell biology·2026
Same journal

A non-proteolytic role of SARS-CoV-2 PLpro in modulating host glycyl-tRNA synthetase activity.

Journal of molecular cell biology·2026
Same journal

ITIH5 drives adipocyte differentiation and obesity-associated metabolic dysregulation via PI3K/AKT signaling activation.

Journal of molecular cell biology·2026
Same journal

β-alanine alleviates gout by inhibiting NLRP3 inflammasome activation.

Journal of molecular cell biology·2026
Same journal

NAD+ subcellular partitioning mediated by miR-183 and miR-96 regulates muscle stem cell differentiation.

Journal of molecular cell biology·2026
See all related articles

Related Experiment Video

Updated: May 24, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

26.9K

Combination therapy dramatically promotes remyelination.

Yawen Li1, Pingping Li1, Yixuan Song1

  • 1Department of Histoembryology, Genetics and Developmental Biology, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Journal of Molecular Cell Biology
|March 4, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a combination therapy (CT) for multiple sclerosis (MS) that effectively reduces inflammation and promotes myelin repair. The novel approach shows promise for improving neurological function and motor recovery in MS patients.

Keywords:
combination therapydemyelinating diseasesimmune modulationoligodendrocyte precursor cellsremyelinationsmall-molecule drugs

More Related Videos

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

4.7K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.2K

Related Experiment Videos

Last Updated: May 24, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

26.9K
Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

4.7K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.2K

Area of Science:

  • Neuroimmunology
  • Regenerative Medicine
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is an incurable immune-mediated CNS disease causing demyelination and progressive disability.
  • Current MS therapies target immune responses but do not promote myelin regeneration, failing to halt disease progression.
  • Small molecules can promote myelin repair but lack sufficient immune modulation for effective MS treatment.

Purpose of the Study:

  • To investigate a combination therapy (CT) for MS that simultaneously modulates immune responses and promotes remyelination.
  • To evaluate the efficacy of CT in promoting oligodendrocyte precursor cell (OPC) differentiation and in situ myelin regeneration.
  • To assess the therapeutic potential of CT in an experimental autoimmune encephalomyelitis (EAE) mouse model of MS.

Main Methods:

  • Developed and applied a combination therapy (CT) in an experimental autoimmune encephalomyelitis (EAE) mouse model.
  • Assessed CT's effects on inflammatory activity, myelin development signaling pathways, and myelin-related gene expression.
  • Evaluated CT's impact on remyelination, oligodendrocyte precursor cell (OPC) differentiation, and motor function recovery.

Main Results:

  • CT significantly suppressed acute inflammatory activity in the EAE model.
  • CT activated myelin development pathways and induced myelin-related gene expression.
  • CT promoted significant remyelination and improved motor performance recovery, with reduced drug dosage achieving comparable results.

Conclusions:

  • The developed combination therapy (CT) effectively addresses the complex pathobiology of MS by combining immunomodulation and active remyelination.
  • CT demonstrates significant potential for promoting myelin regeneration and functional recovery in experimental MS.
  • These findings provide a foundation for developing novel therapeutic strategies for multiple sclerosis.